tiprankstipranks
Trending News
More News >
Corcept Therapeutics Inc. (CORT)
NASDAQ:CORT
US Market

Corcept Therapeutics (CORT) Financial Statements

Compare
1,293 Followers

Corcept Therapeutics Financial Overview

Corcept Therapeutics's market cap is currently $3.80B. The company's EPS TTM is $0.2; its P/E ratio is 43.64; Corcept Therapeutics is scheduled to report earnings on February 24, 2026, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 761.41M$ 675.04M$ 482.38M$ 401.86M$ 365.98M
Gross Profit$ 748.43M$ 664.16M$ 475.89M$ 396.47M$ 360.70M
Operating Income$ 44.80M$ 136.95M$ 107.28M$ 112.63M$ 124.48M
EBITDA$ 68.35M$ 138.29M$ 108.32M$ 113.89M$ 127.95M
Net Income$ 99.65M$ 139.73M$ 106.14M$ 101.42M$ 112.51M
Balance Sheet
Cash & Short-Term Investments$ 372.15M$ 383.33M$ 368.22M$ 431.67M$ 223.53M
Total Assets$ 836.65M$ 840.55M$ 621.52M$ 583.43M$ 423.76M
Total Debt$ 6.11M$ 6.94M$ 151.00K$ 1.14M$ 526.00K
Net Debt$ -114.39M$ -120.73M$ -135.40M$ -65.19M$ -77.09M
Total Liabilities$ 188.85M$ 160.96M$ 114.81M$ 81.59M$ 47.95M
Stockholders' Equity$ 647.80M$ 679.59M$ 506.70M$ 501.84M$ 375.81M
Cash Flow
Free Cash Flow$ 141.78M$ 195.90M$ 126.90M$ 119.91M$ 167.42M
Operating Cash Flow$ 142.00M$ 198.07M$ 127.04M$ 120.32M$ 167.89M
Investing Cash Flow$ 69.76M$ -177.60M$ 90.91M$ -114.33M$ 136.13M
Financing Cash Flow$ -220.37M$ -28.35M$ -148.72M$ -17.28M$ -302.59M
Currency in USD

Corcept Therapeutics Earnings and Revenue History

Corcept Therapeutics Debt to Assets

Corcept Therapeutics Cash Flow

Corcept Therapeutics Forecast EPS vs Actual EPS